Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study
Overview
Reproductive Medicine
Authors
Affiliations
Objective: To investigate gestational trophoblastic neoplasia (GTN), fertility, and pregnancy outcome in molar patients who underwent routine second curettage.
Study Design: Eighty-two patients who visited our hospital for hydatidi- form mole between 2002 and 2011 were registered in this study. All patients had sec- ond curettage around the 7th day after first evacuation. We performed retrospective analysis on several factors between a remission group and a GTN group.
Results: Fourteen patients (17.1%) had chemotherapy after being diagnosed with GTN. Multivariate analysis revealed that the hCG value before first evac- uation was only one independent prognostic factor for GTN. The median follow-up period was 45.5 months, and 41 patients had 62 pregnancies after remission of hydatidiform mole and GTN. The fertility rate was 80% in 45 patients with desire for a baby, and 39 pregnancies (62.9%) ended in live births without congenital malformation.
Conclusion: The incidence of GTN was not lower in hydatidiform mole with routine second curettage. An independent prognostic factor for GTN- was the hCG value before the first evac- uation in molar patients. Our results suggest that rou- tine second curettage does not affect the fertility rate or increase a risk of adverse outcomes in subsequent prej- nancies.
Review of current literature on gestational trophoblastic neoplasia.
Shahzadi M, Khan S, Tariq M, Baloch S, Shahid A, Moosajee M J Egypt Natl Canc Inst. 2023; 35(1):37.
PMID: 38008872 DOI: 10.1186/s43046-023-00195-y.
Epidemiologic study on gestational trophoblastic diseases in Japan.
Yamamoto E, Nishino K, Niimi K, Ino K J Gynecol Oncol. 2022; 33(6):e72.
PMID: 36047375 PMC: 9634103. DOI: 10.3802/jgo.2022.33.e72.
Huang B, Zhao Y, Zhou L, Gong T, Feng J, Han P J Inflamm Res. 2021; 14:3489-3500.
PMID: 34326657 PMC: 8314932. DOI: 10.2147/JIR.S313422.
Yamamoto E, Trinh T, Sekiya Y, Tamakoshi K, Nguyen X, Nishino K Nagoya J Med Sci. 2020; 82(2):183-191.
PMID: 32581399 PMC: 7276412. DOI: 10.18999/nagjms.82.2.183.
Guo Z, Sun Q, Liao Y, Liu C, Zhao W, Li X J Cell Mol Med. 2020; 24(15):8350-8362.
PMID: 32575164 PMC: 7412694. DOI: 10.1111/jcmm.15247.